Media Summary: Dr. Robert Chao discusses LB0001 presented at the EULAR 2022 meeting. Join us for another International Dermatology Education Foundation Series Webinar: Demand More With Dr. Robert Chao discusses abstract 0427 presented at ACR22 convergence. Abstract 0427: Recapture Rates with Ixekizumab ...

Week 3 On Bimzelx - Detailed Analysis & Overview

Dr. Robert Chao discusses LB0001 presented at the EULAR 2022 meeting. Join us for another International Dermatology Education Foundation Series Webinar: Demand More With Dr. Robert Chao discusses abstract 0427 presented at ACR22 convergence. Abstract 0427: Recapture Rates with Ixekizumab ... Author video for 'Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from ... In this interview with trial investigator Mark Lebwohl, MD, Lebwohl discusses new findings from the phase 3b TOGETHER-PsO ... Bimekizumab is a medication used for the treatment of certain diseases in Rheumatology and Dermatology. In Rheumatology, it is ...

Stuck in pain and stiffness that just won't quit? In this interview with HCPLive, Ronald Vender, MD, of Dermatrials Research Inc., highlights key findings after

Photo Gallery

Week 3 on Bimzelx!
How Fast Does Bimzelx Work
Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients
IDEF Educational Series  Demand More With BIMZELX  Transformative Results in Hidradenitis Suppurativ
IDF Educational Series  Demand More With BIMZELX  Transformative Results for Managing Hidradenitis S
What Happens after you stop biologics?
Switching to bimekizumab in plaque psoriasis, G. Kokolakis et al.
Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD
Subcutaneous administering of bimekizumab in a prefilled pen
Bimzelx Inflammatory Relief Explainer
3-Year Patient-Reported Psoriasis Outcomes for Bimekizumab, With Ron Vender, MD
Week 1 on Bimzelx | My Hidradenitis Suppurativa Journey
View Detailed Profile
Week 3 on Bimzelx!

Week 3 on Bimzelx!

Welcome to my

How Fast Does Bimzelx Work

How Fast Does Bimzelx Work

How fast does

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients

Dr. Robert Chao discusses LB0001 presented at the EULAR 2022 meeting.

IDEF Educational Series  Demand More With BIMZELX  Transformative Results in Hidradenitis Suppurativ

IDEF Educational Series Demand More With BIMZELX Transformative Results in Hidradenitis Suppurativ

Join us for another International Dermatology Education Foundation Series Webinar: Demand More With

IDF Educational Series  Demand More With BIMZELX  Transformative Results for Managing Hidradenitis S

IDF Educational Series Demand More With BIMZELX Transformative Results for Managing Hidradenitis S

... on to

What Happens after you stop biologics?

What Happens after you stop biologics?

Dr. Robert Chao discusses abstract 0427 presented at ACR22 convergence. Abstract 0427: Recapture Rates with Ixekizumab ...

Switching to bimekizumab in plaque psoriasis, G. Kokolakis et al.

Switching to bimekizumab in plaque psoriasis, G. Kokolakis et al.

Author video for 'Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from ...

Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD

Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD

In this interview with trial investigator Mark Lebwohl, MD, Lebwohl discusses new findings from the phase 3b TOGETHER-PsO ...

Subcutaneous administering of bimekizumab in a prefilled pen

Subcutaneous administering of bimekizumab in a prefilled pen

Bimekizumab is a medication used for the treatment of certain diseases in Rheumatology and Dermatology. In Rheumatology, it is ...

Bimzelx Inflammatory Relief Explainer

Bimzelx Inflammatory Relief Explainer

Stuck in pain and stiffness that just won't quit?

3-Year Patient-Reported Psoriasis Outcomes for Bimekizumab, With Ron Vender, MD

3-Year Patient-Reported Psoriasis Outcomes for Bimekizumab, With Ron Vender, MD

In this interview with HCPLive, Ronald Vender, MD, of Dermatrials Research Inc., highlights key findings after

Week 1 on Bimzelx | My Hidradenitis Suppurativa Journey

Week 1 on Bimzelx | My Hidradenitis Suppurativa Journey

Welcome to my

Bimzelx Commercial (2024)

Bimzelx Commercial (2024)

Bimzelx Commercial (2024)